The report gives a technical SELL call on Cipla at CMP Rs 1,350 with a stoploss of Rs 1,372 and targets of Rs 1,320 and Rs 1,300.
Read this note →Cipla Limited
NSE CIPLA BSE 500087 INE059A01026
0 filings · 0 analysed
1,403.80
-6.37%
over 5 years
-
The report gives a technical SELL call on Cipla at CMP Rs 1,350 with a stoploss of Rs 1,372 and targets of Rs 1,320 and Rs 1,300.
-
The report lists Cipla among the top gainers on the day, up 0.82-1.74%.
-
Nifty Wrap 22 Oct 26 16 33 47 NiftyWrap (1)
The report lists Cipla as a top gainer in Nifty 50, up 1.29% to 1,330.90.
-
The report notes Cipla was among the top losers, down 0.44-1.43%.
-
The report states Cipla's US sales are expected to decline 27% YoY to USD162m due to g-Revlimid competition, dragging EBITDA down 30% YoY.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| Mirae Asset Sharekhan | 27 Oct 2026, 16:27 | short | 1,355.00 | 1,300.00 | 1,411.00 | -100% | open by 2027-10-27 |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
The report lists Cipla among the top gainers on the day, up 0.82-1.74%.
Read this note →The report lists Cipla as a top gainer in Nifty 50, up 1.29% to 1,330.90.
Read this note →The report notes Cipla was among the top losers, down 0.44-1.43%.
Read this note →The report states Cipla's US sales are expected to decline 27% YoY to USD162m due to g-Revlimid competition, dragging EBITDA down 30% YoY.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief